nach oben

Erschienen in:

01.09.2005 | Experimental

Effects of hyperbaric oxygen treatment on liver functions, oxidative status and histology in septic rats

verfasst von: Sukru Oter, Mustafa Edremitlioglu, Ahmet Korkmaz, Omer Coskun, Dilek Kilic, Ucler Kisa, Hakan Yaren, Hayati Bilgic

Erschienen in: Intensive Care Medicine | Ausgabe 9/2005

Einloggen, um Zugang zu erhalten

Abstract

Objective

The liver is thought to be responsible for multiple organ failure during sepsis. Increase in tissue oxygen consumption is a major component of the septic response. Hyperbaric oxygen (HBO) therapy provides more oxygenation in the whole body. This study examined the effect of HBO alone or in combination with cefepime (CEF) on the liver in septic rats.

Design and interventions

We divided 90 male rats into six groups; control, HBO, sepsis (SEP), SEP+HBO, SEP+CEF, and SEP+CEF+HBO. Sepsis was induced with an intraperitoneal injection of Escherichia coli (2.1×10⁹ cfu). A total of six HBO sessions were performed at 2 atm absolute for 90 min at 6-h intervals. CEF was administered intraperitoneally at a dose of 50 mg/kg twice daily. Animals were killed 48 h after sepsis induction. Their liver and blood were removed for biochemical and histopathological analysis.

Measurements and results

Liver thiobarbituric acid reactive substances as well as serum alanine transaminase, aspartate transaminase and alkaline phosphatase levels increased while the activity of the antioxidant enzymes superoxide dismutase and catalase decreased significantly in septic rats. These parameters returned to nearly control levels in the SEP+CEF+HBO group. Histological observations supported these findings: Hepatocellular degeneration was observed and intensive polymorphonuclear cell infiltration appeared in all fields of septic animal livers. HBO alone could not sufficiently reverse these histopathological changes, but most liver sections presented normal histology when it was combined with CEF.

Conclusions

HBO may be a useful adjuvant therapy modality to improve the efficacy of sepsis treatment.

Moss M, Martin GS (2004) A global perspective on the epidemiology of sepsis. Intensive Care Med 30:527–529CrossRefPubMed

Tu W, Satoi S, Zhang Z, Kitade H, Okumura T, Kwon AH, Kamiyama Y (2003) Hepatocellular dysfunction induced by nitric oxide production in hepatocytes isolated from rats with sepsis. Shock 19:373–377CrossRefPubMed

Molnar RG, Wang P, Ayala A, Ganey PE, Roth RA, Chaudry IH (1997) The role of neutrophils in producing hepatocellular dysfunction during the hyperdynamic stage of sepsis. J Surg Res 73:117–122CrossRefPubMed

Pedoto A, Nandi J, Yang ZJ, Wang J, Bosco G, Oler A, Hakim TS, Camporesi EM (2003) Beneficial effect of hyperbaric oxygen pretreatment on lipopolysaccharide-induced shock in rats. Clin Exp Pharmacol Physiol 30:482–488

Benedetti S, Lamorgese A, Piersantelli M, Pagliarani S, Benvenuti F, Canestrari F (2004) Oxidative stress and antioxidant status in patients undergoing prolonged exposure to hyperbaric oxygen. Clin Biochem 37:312–317CrossRefPubMed

Hart DW, Chinkes DL, Gore DC (2003) Increased tissue oxygen extraction in acidosis with progressive severity of sepsis. J Surg Res 112:49–58CrossRefPubMed

Tibbles PM, Edelsberg JS (1996) Hyperbaric oxygen therapy. N Engl J Med 334:1652–1648CrossRef

Knighton DR, Halliday B, Hunt TK (1986) Oxygen as an antibiotic. Arch Surg 121:191–195PubMed

Bitterman H, Muth CM (2004) Hyperbaric oxygen in systemic inflammatory response. Intensive Care Med 30:1011–1013CrossRefPubMed

10.

Gulec B, Yasar M, Yildiz S, Oter S, Akay C, Deveci S, Sen D (2004) Effect of hyperbaric oxygen on experimental acute distal colitis. Physiol Res 53:493–499PubMed

11.

Korkmaz A, Oter S, Deveci S, Ozgurtas T, Topal T, Sadir S, Bilgic H (2003) Involvement of nitric oxide and hyperbaric oxygen in the pathogenesis of cyclophosphamide induced hemorrhagic cystitis in rats. J Urol 170:2498–2502CrossRefPubMed

12.

Oztas E, Kilic A, Ozyurt M, Korkmaz A, Basustaoglu A (2001) Effect of hyperbaric oxygen and penicillin in a murine model of streptococcal myositis. Undersea Hyperb Med 28:181–186PubMed

13.

Yasar M, Yildiz S, Mas R, Dundar K, Yildirim A, Korkmaz A, Akay C, Kaymakcioglu N, Ozisik T, Sen D (2003) The effect of hyperbaric oxygen treatment on oxidative stress in experimental acute necrotizing pancreatitis. Physiol Res 52:111–116PubMed

14.

Imperatore F, Cuzzocrea S, Luongo C, Liguori G, Scafuro A, De Angelis A, Rossi F, Caputi AP, Filippelli A (2004) Hyperbaric oxygen therapy prevents vascular derangement during zymosan-induced multiple-organ failure syndrome. Intensive Care Med 30:1175–1081CrossRefPubMed

15.

Lu MY, Kang BH, Wan FJ, Chen CS, Huang KL (2002) Hyperbaric oxygen attenuates lipopolysaccharide-induced acute lung injury. Intensive Care Med 28:636–641CrossRefPubMed

16.

Edremitlioglu M, Kilic D, Oter S, Kisa U, Korkmaz A, Coskun O, Bedir O (2005) The effect of hyperbaric oxygen treatment on the renal functions in septic rats: relation to oxidative damage. Surg Today (in press)

17.

Kim KS, Bayer AS (1985) Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci. Antimicrob Agents Chemother 28:51–54PubMed

18.

Escande MC, Herbrecht R (1998) Prospective study of bacteremia in cancer patients. Results of a French multicentre study. Support Care Cancer 6:273–280CrossRefPubMed

19.

Gionis D, Kalabalikis P, Zacharidis B, Moustaki M, Ourani E, Papazoglou K, Papadatos J (2000) Hyperbaric oxygen delivery in treatment of a child with Klippel-Trenaunay syndrome complicated with a limb-threatening Escherichia coli infection. Intensive Care Med 26:355CrossRefPubMed

20.

Thom SR, Lauermann MW, Hart GB (1986) Intermittent hyperbaric oxygen therapy for reduction of mortality in experimental polymicrobial sepsis. J Infect Dis 154:405–510

21.

Okhawa H, Ohshi N, Yagi K (1979) Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358PubMed

22.

Sun Y, Oberley LW, Ying L (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500PubMed

23.

Aebi H (1974) Catalase. In: Bergmeyer HU (ed) Methods of enzymatic analysis, vol II. Academic, New York, pp 673–684

24.

Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin-phenol reagent. J Biol Chem 193:265–275PubMed

25.

Beno DWA, Uhing MR, Jiyamapa-Serna VA, Goto M, Chen Y, Vasan A, Deriy LV, Kimura RE (2003) Differential induction of hepatic dysfunction after intraportal and intravenous challenge with endotoxin and staphylococcal enterotoxin B. Shock 19:352–357CrossRefPubMed

26.

Ayala A, Evans TA, Chaudry IH (1998) Does hepatocellular injury in sepsis involve apoptosis. J Surg Res 76:165–173CrossRefPubMed

27.

Luongo C, Imperatore F, Cuzzocrea S, Filippelli A, Scafuro MA, Mangoni G, Portolano F, Rossi F (1998) Effects of hyperbaric oxygen exposure on a zymosan-induced shock model. Crit Care Med 26:1972–1976CrossRefPubMed

28.

Chishti AD, Shenton BK, Kirby JA, Baudouin SV (2004) Neutrophil chemotaxis and receptor expression in clinical septic shock. Intensive Care Med 30:605–611CrossRefPubMed

29.

Sato T, Tanaka J, Kono Y, Jones RT, Cowley RA, Trump BF (1982) Hepatic cellular injury following lethal Escherichia coli bacteremia in rats. Lab Invest 47:304PubMed

30.

Tsao CM, Ho ST, Chen A, Wang JJ, Tsai SK, Wu CC (2003) Propofol ameliorates liver dysfunction an inhibits aortic superoxide level in conscious rats with endotoxic shock. Eur J Pharmacol 477:183–193CrossRefPubMed

31.

Hsu DZ, Liu MY (2004) Bicuculline methiodide attenuates hepatic injury and decreases mortality in septic rats: role of cytokines. Shock 22:347–350CrossRefPubMed

32.

Maeshima K, Takahashi T, Nakahira K, Shimizu H, Fujii H, Katayama H, Yokoyama M, Morita K, Akagi R, Sassa S (2004) A protective role of interleukin 11 on hepatic injury in acute endotoxemia. Shock 21:134–138CrossRefPubMed

33.

Suntres ZE, Shek PN (1996) Treatment of LPS-induced tissue injury: role of liposomal antioxidants Shock 6:S57–S64

34.

Liaw WJ, Chen TH, Lai ZZ, Chen SJ, Chen A, Tzao C, Wu JY, Wu CC (2005) Effects of a membrane-permeable radical scavenger, tempol, on intraperitoneal sepsis-induced organ injury in rats. Shock 23:88–96CrossRefPubMed

35.

Basile M, Romeo C, Gitto E, Spitz L, Pierro A, Eaton S (2004) Melatonin protects from, but does not reverse, the effects of mediators of sepsis on liver bioenergetics. Pediatr Surg Int 20:263–266CrossRefPubMed

36.

Hink J, Jansen E (2001) Are superoxide and/or hydrogen peroxide responsible for some of the beneficial effects of hyperbaric oxygen therapy? Med Hypotheses 57:764–769CrossRefPubMed

37.

Jamieson D (1989) Oxygen toxicity and reactive oxygen metabolites in mammals. Free Radic Res Commun 7:87–108CrossRef

38.

McCord JM (2000) The evolution of free radicals and oxidative stress. Am J Med 108:652–659CrossRefPubMed

39.

Thom SR (1990) Antagonism of carbon monoxide-mediated brain lipid peroxidation by hyperbaric oxygen. Toxicol Appl Pharmacol 105:340–344CrossRefPubMed

40.

Demirbilek S, Ersoy MO, Demirbilek S, Karaman A, Akın M, Bayraktar M, Bayraktar N (2004) Effects of polyenylphosphatidylcholine on cytokines, nitrite/nitrate levels, antioxidant activity and lipid peroxidation in rats with sepsis. Intensive Care Med 30:1974–1978CrossRefPubMed

41.

Varalakshmi P, Sandhya S, Malarkodi KP (2003) Evaluation of the effect of lipoic acid administered along with gentamicin in rats rendered bacteremic. Mol Cell Biochem 248:35–40CrossRefPubMed

42.

Javesghani D, Hussain SN, Scheidel J, Quinn MT, Magder SA (2003) Superoxide production in the vasculature of lipopolysaccharide-treated rats and pigs. Shock 19:486–493CrossRefPubMed

43.

Topal T, Oter S, Korkmaz A, Sadir S, Metinyurt G, Korkmazhan ET, Serdar MA, Bilgic H, Reiter RJ (2004) Exogenously administered and endogenously produced melatonin reduce hyperbaric oxygen-induced oxidative stress in rat lung. Life Sci 75:461–467CrossRefPubMed

Titel: Effects of hyperbaric oxygen treatment on liver functions, oxidative status and histology in septic rats
verfasst von: Sukru Oter
Mustafa Edremitlioglu
Ahmet Korkmaz
Omer Coskun
Dilek Kilic
Ucler Kisa
Hakan Yaren
Hayati Bilgic
Publikationsdatum: 01.09.2005
Verlag: Springer-Verlag
Erschienen in: Intensive Care Medicine / Ausgabe 9/2005
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-005-2701-6

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Effects of hyperbaric oxygen treatment on liver functions, oxidative status and histology in septic rats